News

ViiV expands licence to allow generic HIV treatment production for low-income countries
By Maggie Fick LONDON (Reuters) -ViiV Healthcare, the HIV-focused joint venture majority owned by GSK, said on Monday it has expanded its licensing deal with the Medicines Patent Pool to allow generic ...
WHO recommends twice-a-year HIV prevention shot as concern looms over funding for global HIV fight
The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, ...
FOX 13 Utah2d
The UN warns millions will die by 2029 if US funding for HIV programs isn't replaced
The U.N. warned that millions could die as a result of the Trump administration ending nearly $4 billion for the global HIV ...
Face2Face Africa3d
Global AIDS battle in crisis after U.S. aid freeze disrupts lifeline programs
U.S. aid cuts to global AIDS programs spark warnings of millions of deaths, as clinics close and progress unravels in ...
AllAfrica on MSN4d
Global Fund Secures Access to Breakthrough HIV Prevention Drug Lenacapavir for Low - and Middle-Income Countries
A pivotal moment in the fight to end AIDS -- ensuring lifesaving innovation reaches those who need it most, wherever they liveThe Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) ...
STAT5d
Gilead to provide HIV prevention drug to 2 million people in lower-income countries at cost
Gilead announced a deal to get its groundbreaking HIV prevention drug to lower income countries. Notably, the deal does not ...
Gilead, Global Fund finalize plan to supply HIV prevention drug to poor countries
Gilead Sciences and the Global Fund to Fight AIDS, Tuberculosis and Malaria said on Wednesday they had finalized plans to supply a long-acting HIV prevention drug to low-income countries, despite the ...
The First Generation Without AIDS Is Within Reach If We Refuse To Settle
This isn’t about managing the AIDS pandemic. It’s about ending it — and letting a new generation grow and thrive free of its ...